-The Economic Times At the peak of Anna Hazare fever last year, anybody disagreeing with his message or prescription was branded pro-corruption. Over the last few weeks, anybody expressing disappointment at the Supreme Court upholding the Right to Education (RTE) Act is being branded anti-poor or elitist. This is unfair and unnecessary: dissent is not treason. The supporters of Anna and RTE have similar traits: impatient, intellectually certain and more interested in...
More »SEARCH RESULT
Total Matching Records found : 2098
Editor-in-Chief of Bihar-Dhirendra K Jha
How an image-fixated chief minister has bent the state’s media to his will If you haven’t heard of an income tax raid on the residential premises of Nitish Kumar’s close aide and treasurer of the ruling Janata Dal-United (JD-U), Vinay Kumar Sinha, you are not alone. Thanks to the local media, it took a while even in Patna—where the house is located—for people to get to know. This, incidentally, is the...
More »Vinod Mehta, Editorial Chairman, Outlook Group interviewed by Hartosh Singh Bal
Q The idea of regulating the media is very much in the news. What are your views on the matter? A Obviously, the ideal way to do this would be self-regulation. I don’t think anyone in the profession has any doubt about that. Everybody agrees that self-regulation is a very good thing, but we don’t seem to move beyond that. And we are consequently opening a window for people who want...
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »Drug approvals fall on account of tardy & tedious process by NDAC-Divya Rajagopal
Confusion sparked by the setting up of a new committee for drug approvals has led to a slide in the number of new medicines getting cleared even as millions of Indians struggle with diabetes and heart failures remain a major killer. The Drug Controller General of India (DCGI) has shed its role as the sole approver of new drugs in the country after a new committee, set up by the health...
More »
